JP2004501646A5 - - Google Patents

Info

Publication number

JP2004501646A5

JP2004501646A5 JP2002506198A JP2002506198A JP2004501646A5 JP 2004501646 A5 JP2004501646 A5 JP 2004501646A5 JP 2002506198 A JP2002506198 A JP 2002506198A JP 2002506198 A JP2002506198 A JP 2002506198A JP 2004501646 A5 JP2004501646 A5 JP 2004501646A5

Authority

JP

Japan

Prior art keywords

canine distemper

distemper virus

antigenome

polynucleotide sequence

nucleic acid

Prior art date

2001-06-22

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 241000712083 Canine morbillivirus Species 0.000 description 16
• 108091033319 polynucleotide Proteins 0.000 description 12
• 102000040430 polynucleotide Human genes 0.000 description 12
• 239000002157 polynucleotide Substances 0.000 description 12
• 238000000034 method Methods 0.000 description 11
• 210000004027 cell Anatomy 0.000 description 7
• 102000039446 nucleic acids Human genes 0.000 description 7
• 108020004707 nucleic acids Proteins 0.000 description 7
• 150000007523 nucleic acids Chemical class 0.000 description 7
• 241000700605 Viruses Species 0.000 description 5
• 239000000203 mixture Substances 0.000 description 5
• 230000002163 immunogen Effects 0.000 description 4
• 241001465754 Metazoa Species 0.000 description 3
• 108090000623 proteins and genes Proteins 0.000 description 3
• 230000035897 transcription Effects 0.000 description 3
• 238000013518 transcription Methods 0.000 description 3
• 239000013598 vector Substances 0.000 description 3
• 108091028043 Nucleic acid sequence Proteins 0.000 description 2
• 239000000427 antigen Substances 0.000 description 2
• 102000036639 antigens Human genes 0.000 description 2
• 108091007433 antigens Proteins 0.000 description 2
• 230000002238 attenuated effect Effects 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 230000002458 infectious effect Effects 0.000 description 2
• 238000004519 manufacturing process Methods 0.000 description 2
• 239000013612 plasmid Substances 0.000 description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 101710137500 T7 RNA polymerase Proteins 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 210000000234 capsid Anatomy 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 230000004186 co-expression Effects 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 210000002308 embryonic cell Anatomy 0.000 description 1
• 238000005538 encapsulation Methods 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 238000003306 harvesting Methods 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 201000005296 lung carcinoma Diseases 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 239000002773 nucleotide Substances 0.000 description 1
• 125000003729 nucleotide group Chemical group 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 239000008194 pharmaceutical composition Substances 0.000 description 1
• 102000004169 proteins and genes Human genes 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1